Legal Representation
Attorney
Frank V. Gallucci
USPTO Deadlines
Application History
39 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Apr 18, 2022 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| Apr 18, 2022 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Jul 28, 2021 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jul 26, 2021 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| Jul 26, 2021 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Jul 26, 2021 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Feb 20, 2021 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Feb 18, 2021 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Feb 18, 2021 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Feb 18, 2021 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jul 31, 2020 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jul 29, 2020 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Jul 29, 2020 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Jul 29, 2020 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jan 24, 2020 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jan 22, 2020 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Jan 22, 2020 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Jan 22, 2020 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Sep 17, 2019 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Aug 2, 2019 | TMBN | T | TTAB RELEASE CASE TO TRADEMARKS | Loading... |
| Aug 2, 2019 | OP.D | T | OPPOSITION DISMISSED NO. 999999 | Loading... |
| Aug 2, 2019 | OP.T | T | OPPOSITION TERMINATED NO. 999999 | Loading... |
| Jul 26, 2018 | OP.I | T | OPPOSITION INSTITUTED NO. 999999 | Loading... |
| Jul 26, 2018 | OPPF | T | OPPOSITION PAPERS RECEIVED AT TTAB | Loading... |
| Jun 26, 2018 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jun 26, 2018 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jun 6, 2018 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| May 18, 2018 | ALIE | A | ASSIGNED TO LIE | Loading... |
| May 9, 2018 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| May 8, 2018 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| May 8, 2018 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| May 8, 2018 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| May 8, 2018 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| May 8, 2018 | GPRA | F | PRIORITY ACTION E-MAILED | Loading... |
| May 8, 2018 | GPRN | O | NOTIFICATION OF PRIORITY ACTION E-MAILED | Loading... |
| May 8, 2018 | CPRA | R | PRIORITY ACTION WRITTEN | Loading... |
| May 3, 2018 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Feb 2, 2018 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jan 26, 2018 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 001
Cell cultures used in industry and science; mammalian cell cultures and viral vectors, being independent replicating pieces of DNA that can transfer DNA sequences, each for manufacture and development in the biotechnology industries
Class 040
Processing and manufacturing of viral vectors, cell cultures, viral vaccines and gene therapy products for use in biotechnology industries to the order and specification of others; manufacture, processing and production of viral vaccines and gene therapy products for use in the biotechnology industries to the order and specification of others
Class 042
Scientific, industrial and technical research, development and analysis services relating to the use of mammalian cell cultures and viral vectors in the field of biotechnology; process development, namely, development of processes for the use of mammalian cell cultures and viral vectors in the manufacture of viral vaccines and gene therapy products; project studies relating to the use of mammalian cell cultures and viral vectors in the field of viral vaccines and gene therapy
Classification
International Classes
001
040
042